InsidersTradesSigma
Follow the 贝瑞基因 stock price and the full insider trade history of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 贝瑞基因 has recorded 5 insider filings. Market capitalisation: €3.1bn. The latest transaction was filed on 11 May 2026 (Sale). Among the most active insiders: 高扬. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
贝瑞基因是一家专注于健康和制药领域的公司，提供基因组和诊断服务。该公司在XSHE市场上市。